PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification.
| Image |  |
|---|---|
| Description | scientific article published on 26 March 2012 |
| Author/s |
author: Edoardo Missiaglia Janet Shipley Jean-Paul Concordet Kathryn Pritchard-Jones Olivier Delattre |
| Publication date | March 26, 2012 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |